Navigation Links
Rigel to Present at JP Morgan Healthcare Conference
Date:1/6/2011

SAN FRANCISCO, Jan. 6, 2011 /PRNewswire/ -- Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today announced that James M. Gower, the company's chairman and chief executive officer, is scheduled to present a company overview at the JP Morgan Healthcare Conference in San Francisco, CA on Thursday, January 13th at 11:30 a.m. PST.

(Logo:  http://photos.prnewswire.com/prnh/20030226/RIGLLOGO)

To access the live audio webcast or the subsequent archived recording, log on to www.rigel.com. Please connect to Rigel's website several minutes prior to the start of the live webcast to ensure adequate time for any software download that may be necessary.

About Rigel (www.rigel.com)Rigel is a clinical-stage drug development company that discovers and develops novel, small-molecule drugs for the treatment of inflammatory and autoimmune disorders, as well as muscle and metabolic diseases. Rigel's pioneering research focuses on intracellular signaling pathways and related targets that are critical to disease mechanisms. Rigel's productivity has resulted in strategic collaborations with large pharmaceutical partners to develop and market its product candidates. Current product development programs include fostamatinib, an oral syk inhibitor that has started its phase 3 clinical trial program for RA, and R343, an inhaled syk inhibitor that is in clinical trials for asthma.Contact: Ryan MaynardPhone: 650.624.1284Email: invrel@rigel.com
'/>"/>

SOURCE Rigel Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. Rigel Announces Third Quarter 2009 Financial Results
2. Rigel Announces Presentations at Two Investor Conferences
3. Rigels R788 Significantly Improves Rheumatoid Arthritis in Phase 2b Clinical Trial
4. Rigel to Host Conference Call to Discuss Results of Its Phase 2b TASKi2 Clinical Trial of R788 in Rheumatoid Arthritis
5. Rigel Commences Phase 2 Trial of R788 in Peripheral T-Cell Lymphomas
6. Shareholder Class Action Filed Against Rigel Pharmaceuticals, Inc. by the Law Firm of Barroway Topaz Kessler Meltzer & Check, LLP
7. Rigel Expects R788 Partnership After Phase 2b Clinical Trials Results
8. Rigels R788 Phase 2a Results Published in Arthritis and Rheumatism
9. Rigel to Host Conference Call to Discuss Preliminary Phase 2 Study Results of R788 in Lymphoma
10. Rigels R788 Slows Progression of Murine Lupus in Preclinical Studies
11. Rigels R788 Shows Preclinical Activity in Type 1 Diabetes Model
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/4/2017)... 4, 2017 The search for test results ... physician/patient consult has long been the goal of healthcare ... focus of the largest meeting of lab professionals and ... market research firm Kalorama Information.  The firm said scores ... or related supplies and software were at the American ...
(Date:8/2/2017)... -- Life Flight Network and PeaceHealth Oregon Network announced they renewed ... operational efficiency for patients at hospitals in Eugene ... Grove , and Florence, Oregon , ... Network work collaboratively to move patients who require the highest ... sensitive emergency exists. ...
(Date:7/31/2017)... TORONTO , July 31, 2017 7D Surgical, ... Spartan Medical has purchased the 7D Surgical System to support ... Washington D.C. and Virginia.  7D Surgical ... Medical for many of the premier medical facilities within those ... ...
Breaking Medicine Technology:
(Date:8/22/2017)... Indiana (PRWEB) , ... August 22, 2017 , ... Although ... Fourth of July, many communities have begun providing weekend displays, and numerous households celebrate ... most humans, they can be downright terrifying for pets. , Kris Zambo, owner ...
(Date:8/21/2017)... Angeles, California (PRWEB) , ... August 21, 2017 ... ... is announcing the addition of two plastic surgery fellows for academic year 2017-2018, ... designed for candidates who have successfully completed residency in Plastic and Reconstructive Surgery. ...
(Date:8/21/2017)... Milwaukee, WI (PRWEB) , ... August 21, 2017 ... ... recent years, with events taking place all over the country. , Outdoor running ... that marathon runners are at an increased risk of melanoma, and only half ...
(Date:8/21/2017)... ... August 21, 2017 , ... The American Hospital Association (AHA) has ... Highmark Health company, to its Board of Trustees for a three-year term beginning January ... care provider organizations and individuals that are committed to the improvement of health in ...
(Date:8/20/2017)... ... August 20, 2017 , ... A total solar eclipse will occur across the U.S. ... the moon moves between the sun and Earth. This rare event will be magnificent to ... help keep you safe on the road during the total eclipse of the sun. , ...
Breaking Medicine News(10 mins):